The new drug that has been FDA-approved is called Korlym. Because Type 2 diabetes is quite common in people who have Cushing's, affecting far more women than men, this drug is specifically tailored for those with Type 2 diabetes. Korlym reduces the effects of the overproduction of cortisol ...